MAPT and Alzheimer disease: Previous studies have shown that rodents injected intracerebroventricular streptozotocin (icv-STZ) show pathological features similar to those of Alzheimer’s disease (AD), such as neuronal loss, accumulation of Aβ, hyperphosphorylation of tau, and impairment of spatial learning.